Radiation Oncology/Therapy: Page 77

ASTRO nabs VA contract to create quality indicators
By AuntMinnie.com staff writers
The U.S. Department of Veterans Affairs (VA) has awarded a one-year contract to the American Society for Radiation Oncology (ASTRO) to develop quality indicators for radiation oncology treatments.
February 13, 2020
2019 09 16 03 57 7061 Astro 2019 400
MIM Software, Sitex team up to treat cancer
By AuntMinnie.com staff writers
Medical imaging software developer MIM Software will collaborate with radiation oncology firm Sirtex Medical to distribute yttrium-90 (Y-90) microspheres and related products around the world.
February 11, 2020
2018 05 16 22 58 8356 Cancer Cell Target2 400
iCAD reports Xoft Axxent milestone
By AuntMinnie.com staff writers
Computer-aided detection (CAD) software developer iCAD said that its Xoft Axxent electronic brachytherapy system has been used to treat a metastatic brain tumor in the U.S. for the first time.
February 11, 2020
2020 02 12 00 58 2867 Xoft Astro2 2019
Mobile CT improves access to lung cancer screening
By Abraham Kim
A mobile CT unit in North Carolina is bringing lung cancer screening directly to the communities of high-risk individuals faced with geographic and socioeconomic barriers to standard screening programs, improving their access to screening services, according to a study slated for publication in the March issue of the Oncologist.
February 11, 2020
2020 02 11 23 40 5336 Samsung Neuro Logica Body Tom Elite Ct 20200211233958
Varian gets FDA nod for Ethos adaptive therapy unit
By AuntMinnie.com staff writers
Radiation therapy firm Varian Medical Systems has garnered U.S. Food and Drug Administration (FDA) clearance for its Ethos system, a radiation therapy platform that utilizes artificial intelligence to adapt treatments in real-time to changes in tumors and patient anatomy.
February 10, 2020
2019 09 15 16 36 2192 Varian Ethos Show Thumb 20190916034947
International Isotopes receives FDA nod for I-131
By AuntMinnie.com staff writers
Radioisotope manufacturer International Isotopes received clearance from the U.S. Food and Drug Administration (FDA) for use of its sodium iodide-131 (I-131) radiopharmaceutical to treat hyperthyroidism and thyroid carcinomas.
February 10, 2020
2016 04 11 16 41 58 174 Approved Stamp 200
Akesis gets FDA clearance for radiosurgery system
By AuntMinnie.com staff writers
Radiation therapy developer Akesis has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Akesis Galaxy RTx radiosurgery system.
February 6, 2020
2018 05 16 22 58 8356 Cancer Cell Target2 400
Eckert & Ziegler to open U.S. isotope facility
By AuntMinnie.com staff writers
Isotope technology firm Eckert & Ziegler has unveiled plans to open a radiopharmaceutical production site in Massachusetts.
February 5, 2020
2018 04 24 20 24 4264 Isotope 400
Accuray touts 2 radiation therapy studies
By AuntMinnie.com staff writers
Radiation oncology firm Accuray is touting results from two studies that investigate the efficacy of its TomoHelical therapy system to treat advanced rectal cancer.
February 5, 2020
2019 09 17 16 01 9179 Accuray Astro 2019
IsoRay, MIM Software team on treatment for head, neck cancer
By AuntMinnie.com staff writers
Medical isotope developer IsoRay will collaborate with medical imaging software developer MIM Software to improve treatment for head and neck cancer.
February 4, 2020
2018 05 16 22 58 8356 Cancer Cell Target2 400
Varian posts strong Q1 sales growth as profit slips
By AuntMinnie.com staff writers
Radiation therapy firm Varian Medical Systems reported 13% growth in revenues for the first quarter of fiscal 2020. The company's net income slipped for the period, however, due mostly to the effect of a large one-time gain in last year's numbers.
January 29, 2020
2020 01 30 01 49 9107 Varian Astro 2019 400
Findings from NELSON trial affirm benefits of CT lung screening
By Abraham Kim
The much-anticipated final results from the Dutch-Belgian Randomized Lung Cancer Screening (NELSON) trial were published online January 29 in the New England Journal of Medicine. The findings reaffirm that CT lung cancer screening can significantly reduce high-risk smokers' likelihood of death from lung cancer.
January 28, 2020
2016 12 21 15 11 05 414 Lung Cancer 400
Previous Page
Page 77 of 468
Next Page